Search results
What Starbucks needs to reverse its 'fall from grace,' according to former CEO Howard Schultz
Quartz· 34 minutes agoFormer Starbucks CEO Howard Schultz has some words of wisdom for the coffee giant after its...
Helldivers 2 CEO responds to Sony officially cancelling PSN account requirement
TweakTown· 5 hours agoThe Helldivers 2 listing was inundated with 200,000 negative reviews, but that is starting to turn...
Quora CEO Adam D’Angelo talks about AI, chatbot platform Poe, and why OpenAI is not a competitor
TechCrunch· 3 hours agoLast November, Adam D'Angelo found himself at the epicenter of one of the biggest controversies in...
Is Snowflake A Buy Amid CEO Change With Q1 Earnings Due?
Investor's Business Daily· 10 minutes agoThe company announced its chief executive, Frank Slootman, will retire. Snowflake said a former top...
Final Credit Suisse CEO, Ulrich Korner, to leave UBS, FT reports
Reuters via Yahoo Finance· 8 hours agoUBS took over Credit Suisse in a government-backed rescue last year in what was the biggest merger...
Steward Health Care, operator of 8 Mass. hospitals, files for bankruptcy
WFXT via Yahoo Finance· 33 minutes agoInaction would worsen health inequities, create hospital deserts, and weaken the entire healthcare...
U.S. automakers like GM are rapidly losing ground in China, once an engine for growth
CNBC· 2 hours agoGeneral Motors CEO Mary Barra has been aggressive in exiting unprofitable or underperforming markets...
Hims & Hers stock rises as CEO clarifies tweet supporting anti-Israel protestors
Seeking Alpha· 2 hours agoShares of Hims & Hers Health (NYSE:HIMS) rebounded premarket Monday following a sharp drop on Friday...
ShotSpotter CEO defends technology
Politico· 32 minutes agoThe reason: Many South and West side aldermen say ShotSpotter is essential to targeting shooting incidents in their wards, which have higher incidents of...
GlycoMimetics fails phase 3 blood cancer trial, causing investors to sour on stock
FierceBiotech· 35 minutes agoGlycoMimetics CEO Harout Semerjian told investors in March that phase 3 blood cancer results could “fundamentally impact our company's trajectory.” Monday, GlycoMimetics reported ...
